Jefferies Reiterates Croda International (COIHF) Buy Recommendation

Jefferies reiterated a Buy recommendation for Croda International (OTCPK:COIHF) on October 17, 2025, despite an average one-year analyst price target of $51.04 suggesting a 6.18% downside from its latest reported closing price of $54.40. The company projects significant growth, with annual revenue expected to increase by 16.25% to 1,939MM and non-GAAP EPS at 2.72. Institutional sentiment remains positive, as evidenced by a 1.21% increase in the number of funds holding COIHF and a 2.25% rise in total institutional shares owned, indicating continued investor confidence despite the potential price target discrepancy.

Analysis

Jefferies reiterated a "Buy" recommendation for Croda International (COIHF) on October 17, 2025, despite the average one-year analyst price target of $51.04/share, as of March 4, 2025, implying a 6.18% downside from its current $54.40 closing price. This discrepancy highlights a divergence between the reiterated rating and the consensus price target, although the target range ($43.14 to $64.43) indicates varied analyst outlooks.

The company's fundamental outlook appears robust, with projected annual revenue of 1,939MM, representing a substantial 16.25% increase. Additionally, the projected annual non-GAAP EPS stands at 2.72, signaling strong operational performance and growth potential that likely underpins the "Buy" rating.

Institutional sentiment remains moderately positive, with 250 funds holding positions, a 1.21% increase in owners, and total shares owned by institutions rising 2.25% to 19,377K. However, while some major funds like MFS Research International Fund A significantly increased their allocation, others like Vanguard Total International Stock Index Fund reduced their portfolio weight, indicating a nuanced, rather than uniformly bullish, institutional conviction.

Key Decisions for Investors

• Investors should carefully weigh the Jefferies "Buy" rating and strong projected fundamentals against the implied downside from the average analyst price target, considering the wide target range.
• Monitor Croda's execution on its projected 16.25% revenue growth and non-GAAP EPS of 2.72, as these metrics will be critical for validating the positive outlook.
• Observe future institutional positioning for clearer conviction trends, given the current mixed signals in portfolio allocations despite overall increased ownership.